Issues in Gastrointestinal Endoscopy: Oesophageal Varices: Inject, Band, Medicate, or Operate

References

• Terblanche J, Burroughs A K, Hobbs K EF. Controversies in the management of bleeding esophageal varices. N Engl J Med 1989; 320: 1393–8, 1469–75
   PubMedGoogle Scholar
• Terblanche J. The surgeon's role in the management of portal hypertension. Ann Surg 1989; 209: 381–95
   PubMedGoogle Scholar
• Terblanche J. Has sclerotherapy altered the management of patients with variceal bleeding?. Am J Surg 1990; 160: 37–42
   PubMed Web of Science ®Google Scholar
• Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 1987; 7: 810–5
   PubMedGoogle Scholar
• Stiegmann G V, Goff J S. Endoscopic esophageal varix ligation (EDL): Preliminary clinical experience. Gastrointest Endosc 1988; 34: 105–8
   Google Scholar
• Goff J S, Reveille R M, Stiegmann G V. Endoscopic sclerotherapy versus endoscopic variceal ligation: symptoms, complications, and motility. Am J Gastroenterol 1988; 83: 1240–4
   PubMedGoogle Scholar
• Goff J S. Esophageal variceal ligation. Can J Gastroenterol 1990; 4: 639–42
   Google Scholar
• Saeed Z A, Michaletz P A, Winchester C B. Endoscopic variceal ligation in patients who have failed endoscopic sclerotherapy. Gastrointest Endosc 1990; 36: 572–4
   PubMedGoogle Scholar
• Reveille R M, Goff J S, Stiegmann G V, Stauffer J T. Combination endoscopic variceal ligation (EVL) and low-volume endoscopic sclerotherapy (ES) for bleeding esophageal varices: a faster route to variceal eradication?. Gastrointest Endosc 1991; 37: 243(A)
   Google Scholar
• Tsai Y-T, Lee F-Y, Lin H-C, et al. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage. Hepatology 1991; 13: 407–12
   PubMed Web of Science ®Google Scholar
• Ready J B, Robertson A D, Rector W G. Effects of vasopressin on portal pressure during hemorrhage from esophageal varices. Gastroenterology 1991; 100: 1411–6
   PubMedGoogle Scholar
• Burroughs A K, McCormick P A, Hughes M D, Sprengers D, D'Heygere F, McLntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388–95
   PubMed Web of Science ®Google Scholar
• McKee R. A study of octreotide in oesophageal varices. Digestion 1990; 45: 60–5, Suppl 1
   PubMed Web of Science ®Google Scholar
• Taranto D, Suozzo R, de Sio I, et al. Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Digestion 1990; 47: 56–60
   Google Scholar
• Kleber G, Sauerbruch T, Fischer G, Geigenberger G, Paumgart-Ner G. Reduction of transmural oesophageal variceal pressure by metoclopramide. J Hepatol 1991; 12: 362–6
   PubMedGoogle Scholar
• Hayes P C, Davis J M, Lewis J A, Bouchier I AD. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990; 336: 153–6
   PubMed Web of Science ®Google Scholar
• Conn H O, Grace N D, Bosch J, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. Hepatology 1991; 13: 902–12
   PubMedGoogle Scholar
• Poynard T, Cales P, Pasta L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991; 324: 1532–8
   PubMed Web of Science ®Google Scholar
• Henderson J M, Warren W D, Millikan W J, Galloway J R, Kawasaki S, Kutner M H. Distal splenorenal shunt with spleno-pancreatic disconnection. A 4-year assessment. Ann Surg 1989; 210: 332–41
   PubMedGoogle Scholar
• Sarfeh I J, Rypins E B, Mason G R. A systematic appraisal of portacaval H-grafts diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204: 356–63
   PubMedGoogle Scholar
• Zemel G, Katzen B T, Becker G J, Benenati J F, Sallee D S. Percutaneous transjugular portosystemic shunt. JAMA 1991; 266: 390–3
   PubMed Web of Science ®Google Scholar
• Roberts J P, Ring E, Lake J R, Sterneck M, Ascher N L. Intrahepatic portacaval shunt for variceal hemorrhage prior to liver transplantation. Transplantation 1991; 52: 160–2
   PubMedGoogle Scholar
• Iwatsuki S, Starzl T E, Todo S, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988; 104: 697–705
   PubMed Web of Science ®Google Scholar
• Pillay P, Starzi T E, Van Thiel D H. Complications of sclerotherapy for esophageal varices in liver transplant candidates. Transplant Proc 1990; 22: 2149–51
   PubMedGoogle Scholar
• Westaby D, Hayes P C, Gimson A ES, Poison R J, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9: 274–7
   PubMed Web of Science ®Google Scholar
• Burroughs A K, Hamilton G, Phillips A, Mezzanotte G, McLntyre N, Hobbs K EF. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857–62
   PubMed Web of Science ®Google Scholar
• Bornman P C, Terblanche J, Kahn D, Jonker M A, Kirsch R E. Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J 1986; 70: 34–6
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, Esnaola S, Villeneuve J P. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology 1989; 96: 1087–92
   PubMed Web of Science ®Google Scholar
• Fleig W E, Stange E F, Hunecke R, et al. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology 1987; 7: 355–61
   PubMed Web of Science ®Google Scholar
• Rossi V, Cales P., Burtin P., et al. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol 1991; 12: 283–9
   PubMedGoogle Scholar
• Beppu K, Inokuchi K, Koyanagi N, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213–8
   PubMed Web of Science ®Google Scholar
• The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319: 983–9
   PubMed Web of Science ®Google Scholar
• Inokuchi K, Cooperative Study Group of Portal Hypertension of Japan. Improved survival after prophylactic portal non-decompression surgery for esophageal varices: a randomized clinical trial. Hepatology 1990; 12: 1–6
   PubMed Web of Science ®Google Scholar
• Triger D R, Smart H L, Hosking S W, Johnson A G. Prophylactic sclerotherapy for esophageal varices: Long-term results of a single-center trial. Hepatology 1991; 13: 117–23
   PubMed Web of Science ®Google Scholar
• De Franchis R, Primignani M, Arcidiacono P G, et al. Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology 1991; 101: 1087–93
   PubMedGoogle Scholar
• The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med 1991; 324: 1779–84
   PubMed Web of Science ®Google Scholar